Product Information

CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.0752 per EA under NDC 62135030801. Its NADAC has been published 272 times since Jun 9, 2021.

FDA first approved this application on Nov 4, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CIPROFLOXACIN HCL 250 MG TAB

Ciprofloxacin hydrochloride
$0.0752per EA

Strength

250 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135030801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CIPROFLOXACIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076896

FDA Approved

11/4/2004

TE Code

AB

On Market Since

4/13/2021

Pharmacological Classes

Cytochrome P450 1A2 Inhibitors
Fluoroquinolone Antibacterial
Fluoroquinolones

Price Statistics

The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 272 times since Jun 9, 2021, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0752 per EA
All-time high$0.1077 (Sep 15, 2021)
All-time low$0.0752 (Aug 19, 2026)
52-week high$0.0917
52-week low$0.0752
Median price$0.0936
Average price$0.0939
Largest weekly change-21.4% (Apr 17, 2024)
Weeks tracked272
Tracking sinceJun 9, 2021

Price History

1W

-5.2%

1M

-5.2%

3M

-14.9%

6M

-13.7%

1Y

-18.0%

3Y

-24.3%

5Y

-30.2%

All

-28.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ciprofloxacin hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Chartwell RX LLC, is $0.0752 per EA (NDC 62135030801), effective Aug 19, 2026.

How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?

Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 28.1%. It has been tracked across 272 weekly CMS publications since Jun 9, 2021.

What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?

Since Jun 9, 2021, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0752 (Aug 19, 2026) to a high of $0.1077 (Sep 15, 2021), with a median of $0.0936 per EA.

Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of CIPROFLOXACIN HCL 250 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CIPROFLOXACIN HCL 250 MG TAB?

CIPROFLOXACIN HCL 250 MG TAB (NDC 62135030801) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.